|
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.A review of the device history record has been completed.No deviations or non-conformances noted.Device evaluation: visual analysis of the returned device identified: crease fold, deformation, wear abrasion, yellow particles in the surface of the shell and overweight.The weight is verified during manufacturing and is within specification for this reason no defect is considered cloudy and voids was observed after autoclave disinfection process.Based on the device analysis the final assessment is: - no issues found related with the manufacturing process.The event of seroma-late is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: seroma-late.
|